<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ujszegi J</submitter><funding>Ministry of Innovation and Technology</funding><funding>National Research and Innovation Office of Hungary</funding><pagination>e0082625</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12403624</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(9)</volume><pubmed_abstract>Survival of amphibian assemblages is threatened by many factors. Among them, chytridiomycosis, the disease caused by the chytrid fungus &lt;i>Batrachochytrium dendrobatidis&lt;/i> (Bd), has great importance, also threatening populations of the yellow-bellied toad (&lt;i>Bombina variegata&lt;/i>), which has a scattered, isolated distribution in Hungary. Treatment with secondary metabolites of the entomopathogenic bacterium &lt;i>Xenorhabdus szentirmaii&lt;/i> is a promising method in the mitigation of chytridiomycosis, as recently demonstrated. To assess whether it may also be effective for lowering infection intensities in &lt;i>B. variegata&lt;/i> tadpoles, we extracted cell-free culture media (CFCM) from liquid cultures of &lt;i>X. szentirmaii&lt;/i> and tested their antifungal efficacy at a dilution of 0.1% (v/v), w</pubmed_abstract><journal>Microbiology spectrum</journal><pubmed_title>Mitigation of chytridiomycosis on &amp;lt;i&amp;gt;Bombina variegata&amp;lt;/i&amp;gt; tadpoles with the antimicrobial metabolites of the bacterium &amp;lt;i&amp;gt;Xenorhabdus szentirmaii&amp;lt;/i&amp;gt;.</pubmed_title><pmcid>PMC12403624</pmcid><funding_grant_id>PD-142654</funding_grant_id><funding_grant_id>ÚNKP-23-6</funding_grant_id><funding_grant_id>ÚNKP-23-4, EKÖP-24-4</funding_grant_id><funding_grant_id>ÚNKP-22-3, ÚNKP-23-4</funding_grant_id><pubmed_authors>Toth AG</pubmed_authors><pubmed_authors>Ujszegi J</pubmed_authors><pubmed_authors>Magos G</pubmed_authors><pubmed_authors>Voros J</pubmed_authors><pubmed_authors>Boros Z</pubmed_authors><pubmed_authors>Harmos K</pubmed_authors><pubmed_authors>Kasler A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Mitigation of chytridiomycosis on &amp;lt;i&amp;gt;Bombina variegata&amp;lt;/i&amp;gt; tadpoles with the antimicrobial metabolites of the bacterium &amp;lt;i&amp;gt;Xenorhabdus szentirmaii&amp;lt;/i&amp;gt;.</name><description>Survival of amphibian assemblages is threatened by many factors. Among them, chytridiomycosis, the disease caused by the chytrid fungus &lt;i>Batrachochytrium dendrobatidis&lt;/i> (Bd), has great importance, also threatening populations of the yellow-bellied toad (&lt;i>Bombina variegata&lt;/i>), which has a scattered, isolated distribution in Hungary. Treatment with secondary metabolites of the entomopathogenic bacterium &lt;i>Xenorhabdus szentirmaii&lt;/i> is a promising method in the mitigation of chytridiomycosis, as recently demonstrated. To assess whether it may also be effective for lowering infection intensities in &lt;i>B. variegata&lt;/i> tadpoles, we extracted cell-free culture media (CFCM) from liquid cultures of &lt;i>X. szentirmaii&lt;/i> and tested their antifungal efficacy at a dilution of 0.1% (v/v), w</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-05-29T17:21:01.084Z</modification><creation>2026-04-08T05:33:38.884Z</creation></dates><accession>S-EPMC12403624</accession><cross_references><pubmed>40757867</pubmed><doi>10.1128/spectrum.00826-25</doi></cross_references></HashMap>